Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	127.76	104.81	150.15	185.54	441.59	214.47
Short-Term Investments	192.92	203.46	295.4	274.84	9.82	-
Cash & Short-Term Investments	320.68	308.27	445.55	460.38	451.41	214.47
Cash Growth	6.58%	-30.81%	-3.22%	1.98%	110.48%	-8.49%
Receivables	103.34	119.69	93.07	89.88	61.23	34.18
Inventory	170.45	145.29	80.12	33.89	11.89	17.23
Prepaid Expenses	14.2	10.4	12.07	9.6	5.51	2.66
Total Current Assets	608.67	583.65	630.81	593.74	530.03	268.54
Property, Plant & Equipment	126.93	121.4	95.24	62.65	24.13	16.41
Long-Term Investments	111.78	112.73	81.6	19.54	10.5	9.94
Long-Term Deferred Tax Assets	77.58	88.67	0.01	-	-	-
Other Long-Term Assets	1.03	0.86	0.73	0.88	0.22	0.2
Total Assets	925.99	907.32	808.38	676.81	564.88	295.08

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	27.1	36.57	38.69	38.84	26.85	11.67
Accrued Expenses	44.08	54.29	45.52	37.59	32.08	19.67
Current Portion of Long-Term Debt	-	-	-	-	-	9.19
Current Portion of Leases	-	2.16	1.75	-	1.34	0.31
Current Income Taxes Payable	-	2.45	1.61	0.58	-	-
Other Current Liabilities	-	0.59	0.93	1.1	0.92	0.47
Total Current Liabilities	71.18	96.06	88.5	78.11	61.19	41.31
Long-Term Debt	-	-	-	-	-	15.8
Long-Term Leases	29.09	30	30.04	24.85	7.54	8.8
Other Long-Term Liabilities	0.14	0.1	0.15	1.35	0.15	0.13
Total Liabilities	100.41	126.16	118.69	104.3	68.87	66.04

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.03	0.03	0.03	0.03	0.03	0.03
Additional Paid-In Capital	983.67	927.16	981.04	917.11	820.34	508.47
Retained Earnings	-157.47	-146.49	-291.91	-345.42	-324.27	-279.39
Comprehensive Income & Other	-0.65	0.46	0.54	0.8	-0.09	-0.06
Total Common Equity	825.58	781.16	689.7	572.51	496.01	229.05
Shareholders' Equity	825.58	781.16	689.7	572.51	496.01	229.05
Total Liabilities & Equity	925.99	907.32	808.38	676.81	564.88	295.08

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	29.09	32.16	31.79	24.85	8.87	34.1
Net Cash (Debt)	291.59	276.11	413.75	435.53	442.54	180.37
Net Cash Growth	8.87%	-33.27%	-5.00%	-1.58%	145.35%	-11.46%
Net Cash Per Share	9.94	9.28	13.55	14.86	15.76	6.62
Filing Date Shares Outstanding	28.91	28.59	29.67	29.59	29.05	27.53
Total Common Shares Outstanding	28.91	28.58	29.74	29.56	29.01	27.42
Working Capital	537.49	487.6	542.31	515.63	468.85	227.23
Book Value Per Share	28.56	27.33	23.19	19.37	17.10	8.35
Tangible Book Value	825.58	781.16	689.7	572.51	496.01	229.05
Tangible Book Value Per Share	28.56	27.33	23.19	19.37	17.10	8.35
Machinery	-	54.21	34.1	9.42	8.24	6.08
Construction In Progress	-	24.38	24.98	33.21	11.86	5.18
Leasehold Improvements	-	11.77	10.06	2.36	2.06	0.28

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error